Updates are available Correction dated 2020-12-17
Click to view Correction: https://doi.org/10.1038/s41587-020-00792-5
-
Authors
Cohen, Ron https://orcid.org/0000-0002-9152-5114
Francois, Cedric
Crowley, John
Hastings, Paul
King, Rachel
Love, Ted W.
Maraganore, John
McMurry-Heath, Michelle
Levin, Jeremy https://orcid.org/0000-0003-4692-4797
,
Adams, Chris
Al-Shamma, Sunny
Anderson, Bonnie
Anzalone, Christopher R.
Aspinall, Mara G.
Audia, James E.
Babler, Martin
Bacha, Jeffrey
Bailey, Michael P.
Bardon, Christiana
Barrett, Mark
Barrett, Peter
Becraft, Jacob
Bird, Jeffrey
Bitterman, Kevin
Blum, Robert
Bolno, Paul
Bonney, Michael
Booth, Bruce
Bosley, Katrine S.
Boyce, Sarah
Bozilenko, Marina
Burns, Jim
Byers, Brook
Cashman, John
Cayer, Devon
Chee, Brian
Clark, Chip
Cleland, Jeffrey
Coulter, Ivan
Cox, Gerald F.
Crane, Alan
Culley, Brian
Dabbagh, Karim
Dahiyat, Bassil
de Boer, Daniel A.
De Fougerolles, Tony
Deitcher, Steven R.
Demy, Sara Jane
Doerfler, Douglas
Dube, Eric
Earp, David J.
Ehrlich, Hartmut
Elms, Steve
Embury, Stephen H.
Epstein, David R.
Exter, Neil
Ezekowitz, Alan
Fambrough, Douglas
Farr, Stephen J.
Fetzer, Oliver
Forbes, Alexandria
Formela, J. F.
Foukes, Gordon
Fouse, Jackie
Fowler, John
Frank, Frederick
Ganot, Ilan
Gardner, Jason
Gibson, Christopher
Gorgas, Gregory
Graves, Kurt
Grayzel, David
Greene, Barry
Greenstreet, Yvonne
Gujrathi, Sheila
Haak-Frendscho, Mary
Hagan, John
Hallal, David
Hallam, Tom
Halloran, Laurie
Haseltine, William
Hasnain, Faheem
Heifetz, Peter B.
Hermiston, Terry
Herz, Jeffrey
Heyman, Richard
Holmlin, Erik
Hompesch, Marcus
Hutton, Wende
Ingram, Douglas S.
Johnson, John H.
Karsen, Perry
Kawahata, Douglas
Kaye, Edward M.
Kjellson, Nina
Ko Ferrigno, Paul
Krenn, Mike
Kriegsman, Steven
Kumar, Neil
LaMattina, John
Langer, Robert
Larwood, David
Lawrence, Matthew
Leerink, Jeff
Legoretta, Pablo
Leiden, Jeff
Leschly, Nick
Levin, Mark
Linthwaite, Christopher
Longman, Roger
Luderer, Albert
Macrae, Sandy
Mahmood, Tahir
Markus, Richard
Martin, Tyler
McCarthy, Sean
McCracken, Lee
McGuire, Terry
Mederis, Gail
Mackay, James
McMahon, Jerry
Milne, Jill C.
Miloni, Mauro
Moch, Kenneth I.
Mola, Paul
Monia, Brett
Moos, Walter
Morrison, Scott W.
Munshi, Amit
Murcko, Mark
Nashat, Amir
Newell, William J.
Nichtberger, Steven
Ors, Frederic
Papadopoulos, Stelios
Parker, H. Stewart
Parks, Elliot
Parmar, Kush M.
Payne, Joseph
Perry, Mark
Pfeffer, Cary G.
Polvino, William J.
Pruzanski, Mark
Purcell, Dennis J.
Pyott, David E. I.
Raab, Michael G.
Raythatha, Jigar
Register, R. Bruce
Renaud, Ronald Jr
Renton, Hollings
Rhodes, Christopher
Rhodes, Jason
Richman, Michael
Robin, Howard
Robbins, Wendye
Rutter, William J.
Sapirstein, James
Sato, Vicki
Sblendorio, Glenn
Scangos, George
Scarlett, John A.
Schiff, Drew
Schikan, Hans
Scibetta, James
Schulman, Amy
Scott, Tim
Sekhri, Paul
Seth, Alpna
Sherwin, Stephen A.
Short, Jay M.
Simon, Mark
Simonian, Nancy
Sinha, Vikas
Sivola, Tero
Slaoui, Moncef
Smith, Julie Anne
Smith, Erika R.
Sommadossi, Jean-Pierre
Soteropoulos, Paula
Souceck, Laura
Stiles, Travis
Stocks, Clifford J.
Stover, David
Suckow, Arthur
Szela, Mary T.
Tepper, Robert
Topol, Eric
Turenne, Andre
Velleca, Mark
Venkayya, Rajeev
Verdugo, Dawn
Walts, Alan
Wang, Bing
Warma, Neil
Wasserman, Scott
Ward, Robert
Webb, David
Weston, Claire
Westphal, Christoph
Wilson, James M.
Wilson, Mark S.
Winningham, Rick
You, Angie
Zakes, Bradford
Zerhouni, Elias A.
Zohar, Daphne
Zweifach, Sandy
- License Information
-
More Information
Article History
First Online: 25 November 2020
Change Date: 17 December 2020
Change Type: Correction
Change Details: A Correction to this paper has been published: https://doi.org/10.1038/s41587-020-00792-5.
Competing interests
: Ron Cohen is president and CEO, Acorda Therapeutics; Cedric Francois is president and CEO, Apellis Pharmaceuticals; John Crowley is chairman and CEO, Amicus Therapeutics; Paul Hastings is president and CEO, Nkarta Therapeutics; Rachel King is CEO, GlycoMimetics; Ted W. Love is president and CEO, Global Blood Therapeutics; John Maraganore is CEO, Alnylam Pharmaceuticals; Michelle McMurry-Heath is president and CEO, Biotechnology Innovation Organization; Jeremy Levin is chairman and CEO, Ovid Therapeutics, and chairman, Biotechnology Innovation Organization. This Correspondence represents solely the individual and personal views of the authors and signatories, and not those of their respective companies.
